Developer docs
API playgroundTry for free, no card

Search company profiles

Affidea Polska

Full company profile

uuid003tudx

Namestring
Affidea Polska
Legal namestring
Affidea Sp. z o.o.
Websiteurl
affidea.pl
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Affidea Polska is a private Polish healthcare operator providing diagnostic imaging and oncological treatment services through a network of 43 medical facilities across 31 cities. The company performs approximately 500,000 examinations per year, accounting for an estimated 10% of MRI examinations and 20% of PET/CT examinations in Poland, and operates 6 radiotherapy centers including International Oncology Centers in Koszalin and Poznań and Affidea NU-MED facilities. Service offerings span MRI, CT, PET/CT (including PET/CT-PSMA for prostate cancer), scintigraphy, ultrasound, X-ray, virtual colonoscopy, and oncology care including radiotherapy, brachytherapy, teletherapy, and combined hyperthermia treatment.

The technology foundation rests on advanced diagnostic imaging equipment paired with specialized software and examination protocols, including a EuroSafe Imaging-recognized Dose Excellence program for radiation safety. Adjacent services include one-day surgery (Affidea Lublin), clinical trials, and a teleradiology service. The company operates dedicated patient and physician portals for appointment scheduling, results retrieval, and referring physician workflows. The group lives within the broader Affidea Europe network (14 countries, 420+ facilities, 20M examinations/year), and Polish operations are conducted through two legal entities: Affidea Sp. z o.o. (diagnostic imaging) and Affidea Onkoterapia Sp. z o.o. (radiotherapy).

Affidea Polska's revenue model is a hybrid of publicly reimbursed and private-pay diagnostic and treatment services. Reimbursement is contracted through the Polish National Health Fund (NFZ) for insured patients, complemented by private examination pricing with per-test unit economics and location-specific downloadable price lists. Customer segments span the general patient population, cancer patients (oncology), referring physicians, and neurological patients (Affidea neuraCare memory disorders). Marketing and distribution are primarily through direct facility access, with phone-based and online appointment booking, physician referral networks, and NFZ contractual channels.

Short descriptiontext

Affidea Polska operates 43 diagnostic imaging and oncology facilities across 31 Polish cities, performing approximately 500,000 examinations annually and serving both NFZ-reimbursed and private-pay patients, including general diagnostics, cancer care, and memory disorder services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWarsaw, Poland
HQ citystring
Warsaw
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices34 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic imaging, oncology treatment, radiotherapy services, medical imaging center, cancer care
Industry4 codes
PRIMARYHLAFAKAB
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
SECONDARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAKAA
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
SECONDARYHLAKAFAB
Medical Oncology
NAICS code3 codes
  • Diagnostic Imaging Centers621512
  • Specialty (except Psychiatric and Substance Abuse) Hospitals62231
  • Offices of Physicians62111
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Health Services8000
Product category
Diagnostic Imaging and Oncology Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Imaging Services
TypeSubscription Recurring
Description

Medical diagnostic imaging services including MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, and virtual colonoscopy. Revenue generated through NFZ reimbursement and private patient payments.

affidea.pl
2Oncological Treatment Services
TypeSubscription Recurring
Description

Radiotherapy, teleradiotherapy, brachytherapy, and combined treatment including consultations, imaging diagnostics, and radiation therapy for cancer patients. Provided through Affidea Onkoterapia Sp. z o.o.

affidea.pl
3Hospital and Day Surgery Services
TypeSubscription Recurring
Description

Affidea Lublin operates as a hospital providing one-day surgery services

affidea.pl
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details2 tiers
1NFZ-funded services
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Medical services covered by National Health Fund (NFZ) reimbursement for eligible patients

affidea.pl
2Private examination pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual examination pricing varies by location. Downloadable price lists available for MR, CT, PET/CT, USG, and X-ray at each facility.

affidea.pl
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Affidea NU-MED
Description

Oncology treatment centers providing radiotherapy, teletherapy, brachytherapy, and combined oncology treatment

affidea.pl
+2 more records
Core offering1 text field

Affidea Polska operates a national network of 43 diagnostic imaging and oncology treatment facilities across 31 Polish cities, employing 500 specialists to deliver MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy, radiotherapy, brachytherapy, combined hyperthermia, oncology consultations, clinical trials, and teleradiology services. Offerings are paid via NFZ reimbursement, private insurance, or self-pay.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1 in 10 MRI examinations in Poland performed at Affidea facilities
+3 more records
Product overview1 text field

Affidea Polska operates as a network of 43 medical facilities across 31 cities in Poland, offering diagnostic imaging and oncological treatment services. The company provides a unified platform of imaging services (MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy) supported by specialized oncology treatment centers offering radiotherapy, brachytherapy, and combined therapies. Key facility brands include Affidea NU-MED (oncology centers), Międzynarodowe Centra Onkologii (International Oncology Centers in Koszalin and Poznań), and Affidea neuraCare (memory disorder center in Warsaw). The network also includes one-day surgery at Affidea Lublin, clinical trial services, and digital portals for patients and physicians. Services are delivered through NFZ (public health insurance) reimbursement and private pay models.

Product and service1 record
1Diagnostic Imaging Services
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1National Health Fund (NFZ)
Strategic tierCoreTypeOthers
Description

NFZ (Narodowy Fundusz Zdrowia) is the Polish National Health Fund providing public health insurance. Affidea operates as a contracted provider offering diagnostic imaging and oncology services covered under the public healthcare system, enabling access to services for insured patients.

affidea.pl
2Fundacja Affidea NU-MED
Strategic tierSupportingTypeOthers
Description

Affidea NU-MED Foundation supports charitable activities and patient assistance programs. The foundation enables community support and social responsibility initiatives for cancer patients and their families.

affidea.pl
3KPO (Krajowy Plan Odbudowy) - National Recovery Plan
Strategic tierStrategicTypeOthers
Description

KPO (National Recovery Plan) is a European Union funding mechanism for post-pandemic recovery. Affidea received KPO funding for oncology projects including modernization of accelerator facilities and linear accelerator replacement at the International Oncology Center in Koszalin, as well as comprehensive treatment planning system upgrades.

affidea.pl
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight9 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major European medical diagnostics and imaging provider. Comparable to Affidea Europe/Polska as a large incumbent in multi-country diagnostic imaging and laboratory services with NFZ-style public reimbursement exposure.

TypeDirect peer
Description

National network of medical laboratories offering diagnostic testing across Poland. Comparable to Affidea's diagnostic services arm on multi-site NFZ-contracted operations and broad geographic coverage.

TypeDirect peer
Description

One of the largest private diagnostic imaging and laboratory networks in Poland, operating MRI, CT, PET/CT, and lab services across multiple cities. Directly comparable to Affidea Polska in modality mix, NFZ contract reliance, and multi-site operating model.

TypeRegional player
Description

Private healthcare network in Warsaw delivering outpatient diagnostics, imaging, and specialist consultations. Comparable to Affidea's Warsaw facilities on advanced imaging and specialist-led outpatient services.

TypeDirect peer
Description

Polish diagnostic laboratory and imaging network operated within the Medicover group. Overlaps with Affidea on lab and imaging services delivered through multi-site centers under NFZ and private reimbursement.

TypeDirect peer
Description

Largest private healthcare provider in Poland, offering outpatient diagnostics, imaging, and specialty care. Overlaps with Affidea on advanced imaging and outpatient specialist services, with similar NFZ/private mix and large-city density.

TypeBroad incumbent
Description

European diagnostic services provider offering imaging and laboratory services across multiple countries. Comparable to Affidea Europe as a continental-scale incumbent in cross-border diagnostic imaging and lab operations.

TypeDirect peer
Description

Integrated private healthcare operator in Poland providing diagnostics, specialty clinics, and hospital services. Comparable to Affidea's multi-site outpatient and specialty footprint, including imaging and oncology-adjacent services.

TypeBroad incumbent
Description

Pan-European parent operating 420+ diagnostic imaging and oncology facilities across 14 countries. Comparable as the broader incumbent owner of Affidea Polska, providing capital, procurement, and clinical standards across the network.

TypeRegional player
Description

Private healthcare operator in northern Poland offering diagnostics, specialty clinics, and surgical services. Comparable to Affidea on multi-modality private outpatient services in overlapping Polish regions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Affidea Polska

Diagnostic Imaging and Oncology Servicesaffidea.pl

Affidea Polska operates 43 diagnostic imaging and oncology facilities across 31 Polish cities, performing approximately 500,000 examinations annually and serving both NFZ-reimbursed and private-pay patients, including general diagnostics, cancer care, and memory disorder services.

What Affidea Polska does

Affidea Polska is a private Polish healthcare operator providing diagnostic imaging and oncological treatment services through a network of 43 medical facilities across 31 cities. The company performs approximately 500,000 examinations per year, accounting for an estimated 10% of MRI examinations and 20% of PET/CT examinations in Poland, and operates 6 radiotherapy centers including International Oncology Centers in Koszalin and Poznań and Affidea NU-MED facilities. Service offerings span MRI, CT, PET/CT (including PET/CT-PSMA for prostate cancer), scintigraphy, ultrasound, X-ray, virtual colonoscopy, and oncology care including radiotherapy, brachytherapy, teletherapy, and combined hyperthermia treatment.

The technology foundation rests on advanced diagnostic imaging equipment paired with specialized software and examination protocols, including a EuroSafe Imaging-recognized Dose Excellence program for radiation safety. Adjacent services include one-day surgery (Affidea Lublin), clinical trials, and a teleradiology service. The company operates dedicated patient and physician portals for appointment scheduling, results retrieval, and referring physician workflows. The group lives within the broader Affidea Europe network (14 countries, 420+ facilities, 20M examinations/year), and Polish operations are conducted through two legal entities: Affidea Sp. z o.o. (diagnostic imaging) and Affidea Onkoterapia Sp. z o.o. (radiotherapy).

Affidea Polska's revenue model is a hybrid of publicly reimbursed and private-pay diagnostic and treatment services. Reimbursement is contracted through the Polish National Health Fund (NFZ) for insured patients, complemented by private examination pricing with per-test unit economics and location-specific downloadable price lists. Customer segments span the general patient population, cancer patients (oncology), referring physicians, and neurological patients (Affidea neuraCare memory disorders). Marketing and distribution are primarily through direct facility access, with phone-based and online appointment booking, physician referral networks, and NFZ contractual channels.

Affidea Polska firmographics

Firmographics
Name
Affidea Polska
Legal name
Affidea Sp. z o.o.
Website
https://affidea.pl
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Short description
Affidea Polska operates 43 diagnostic imaging and oncology facilities across 31 Polish cities, performing approximately 500,000 examinations annually and serving both NFZ-reimbursed and private-pay patients, including general diagnostics, cancer care, and memory disorder services.
Ownership category
akta.pro rank

Affidea Polska industry classification

Industry
Product category
Diagnostic Imaging and Oncology Services
NAICS
Diagnostic Imaging Centers (621512), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Physicians (62111)
SIC
Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAFAKAB
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
SECONDARYHLAFAHAC
Oncology & Cancer Specialty Hospitals
Healthcare & Life Sciences/Healthcare Providers & Systems/Specialty Hospitals & Inpatient Specialty Care
SECONDARYHLAFAKAA
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
SECONDARYHLAKAFAB
Medical Oncology

Keywords

  • Diagnostic imaging
  • Oncology treatment
  • Radiotherapy services
  • Medical imaging center
  • Cancer care

Where Affidea Polska is headquartered

Location

Headquarters

HQ city
Warsaw
HQ country
Poland
HQ region
Europe

Offices34 records

Markets served

Affidea Polska business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Diagnostic Imaging Services: Medical diagnostic imaging services including MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, and virtual colonoscopy. Revenue generated through NFZ reimbursement and private patient payments.
  2. Oncological Treatment Services: Radiotherapy, teleradiotherapy, brachytherapy, and combined treatment including consultations, imaging diagnostics, and radiation therapy for cancer patients. Provided through Affidea Onkoterapia Sp. z o.o.
  3. Hospital and Day Surgery Services: Affidea Lublin operates as a hospital providing one-day surgery services

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goNFZ-funded services
Unit PricingPay-as-you-goPrivate examination pricing

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Affidea Polska product offering

Product offering

Core offering

Affidea Polska operates a national network of 43 diagnostic imaging and oncology treatment facilities across 31 Polish cities, employing 500 specialists to deliver MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy, radiotherapy, brachytherapy, combined hyperthermia, oncology consultations, clinical trials, and teleradiology services. Offerings are paid via NFZ reimbursement, private insurance, or self-pay.

Product overview

Affidea Polska operates as a network of 43 medical facilities across 31 cities in Poland, offering diagnostic imaging and oncological treatment services. The company provides a unified platform of imaging services (MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy) supported by specialized oncology treatment centers offering radiotherapy, brachytherapy, and combined therapies. Key facility brands include Affidea NU-MED (oncology centers), Międzynarodowe Centra Onkologii (International Oncology Centers in Koszalin and Poznań), and Affidea neuraCare (memory disorder center in Warsaw). The network also includes one-day surgery at Affidea Lublin, clinical trial services, and digital portals for patients and physicians. Services are delivered through NFZ (public health insurance) reimbursement and private pay models.

Differentiator

Problem solved

Functional benefit

Brands

  • Affidea NU-MED: Oncology treatment centers providing radiotherapy, teletherapy, brachytherapy, and combined oncology treatment
  • Affidea neuraCare
  • Międzynarodowe Centra Onkologii Affidea

Products and services

  • Diagnostic Imaging Services

Quantifiable outcome

  • 1 in 10 MRI examinations in Poland performed at Affidea facilities
  • +3 more outcomes

Companies that use Affidea Polska

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Affidea Polska technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Affidea Polska partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core, supporting and strategic.

  • National Health Fund (NFZ)coreOthersNFZ (Narodowy Fundusz Zdrowia) is the Polish National Health Fund providing public health insurance. Affidea operates as a contracted provider offering diagnostic imaging and oncology services covered under the public healthcare system, enabling access to services for insured patients.
  • Fundacja Affidea NU-MEDsupportingOthersAffidea NU-MED Foundation supports charitable activities and patient assistance programs. The foundation enables community support and social responsibility initiatives for cancer patients and their families.
  • KPO (Krajowy Plan Odbudowy) - National Recovery PlanstrategicOthersKPO (National Recovery Plan) is a European Union funding mechanism for post-pandemic recovery. Affidea received KPO funding for oncology projects including modernization of accelerator facilities and linear accelerator replacement at the International Oncology Center in Koszalin, as well as comprehensive treatment planning system upgrades.

Scale indicators8 records

Recent moves6 records

Expansion highlights9 records

Affidea Polska competitors and assessment

Company assessment

Broad incumbents

  • Synlab: Major European medical diagnostics and imaging provider. Comparable to Affidea Europe/Polska as a large incumbent in multi-country diagnostic imaging and laboratory services with NFZ-style public reimbursement exposure.
  • Unilabs: European diagnostic services provider offering imaging and laboratory services across multiple countries. Comparable to Affidea Europe as a continental-scale incumbent in cross-border diagnostic imaging and lab operations.
  • Affidea Group (Affidea Europe): Pan-European parent operating 420+ diagnostic imaging and oncology facilities across 14 countries. Comparable as the broader incumbent owner of Affidea Polska, providing capital, procurement, and clinical standards across the network.

Direct peers

  • ALAB laboratoria: National network of medical laboratories offering diagnostic testing across Poland. Comparable to Affidea's diagnostic services arm on multi-site NFZ-contracted operations and broad geographic coverage.
  • Diagnostyka S.A. One of the largest private diagnostic imaging and laboratory networks in Poland, operating MRI, CT, PET/CT, and lab services across multiple cities. Directly comparable to Affidea Polska in modality mix, NFZ contract reliance, and multi-site operating model.
  • Synevo (Medicover): Polish diagnostic laboratory and imaging network operated within the Medicover group. Overlaps with Affidea on lab and imaging services delivered through multi-site centers under NFZ and private reimbursement.
  • LUX MED (Bupa): Largest private healthcare provider in Poland, offering outpatient diagnostics, imaging, and specialty care. Overlaps with Affidea on advanced imaging and outpatient specialist services, with similar NFZ/private mix and large-city density.
  • Medicover: Integrated private healthcare operator in Poland providing diagnostics, specialty clinics, and hospital services. Comparable to Affidea's multi-site outpatient and specialty footprint, including imaging and oncology-adjacent services.

Regional players

  • Centrum Medyczne Damiana: Private healthcare network in Warsaw delivering outpatient diagnostics, imaging, and specialist consultations. Comparable to Affidea's Warsaw facilities on advanced imaging and specialist-led outpatient services.
  • Swissmed Centrum Zdrowia: Private healthcare operator in northern Poland offering diagnostics, specialty clinics, and surgical services. Comparable to Affidea on multi-modality private outpatient services in overlapping Polish regions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Affidea Polska social profiles

Digital presence

Affidea Polska financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Affidea Polska leadership team

Management profile

Number of profiles

Affidea Polska subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Affidea Polska funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Affidea Polska M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Affidea Polska

What does Affidea Polska do?

Affidea Polska operates a national network of 43 diagnostic imaging and oncology treatment facilities across 31 Polish cities, employing 500 specialists to deliver MRI, CT, PET/CT, scintigraphy, ultrasound, X-ray, virtual colonoscopy, radiotherapy, brachytherapy, combined hyperthermia, oncology consultations, clinical trials, and teleradiology services. Offerings are paid via NFZ reimbursement, private insurance, or self-pay.

Is Affidea Polska a public or private company?

Affidea Polska is a private company. It is classified as corporate owned and is currently operating.

When was Affidea Polska founded?

Affidea Polska was founded in 2000. It employs 101 to 250 people.

Where is Affidea Polska based?

Affidea Polska is headquartered in Warsaw, Poland, in the Europe region.

How does Affidea Polska make money?

Three revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are oncological Treatment Services and hospital and Day Surgery Services.

Who are Affidea Polska's main competitors?

Broad incumbents on record are Synlab, Unilabs and Affidea Group (Affidea Europe). Direct peers are ALAB laboratoria, Diagnostyka S.A., Synevo (Medicover), LUX MED (Bupa) and Medicover. Regional players are Centrum Medyczne Damiana and Swissmed Centrum Zdrowia.

Does Affidea Polska have an API?

No public API is recorded for Affidea Polska.

What industry is Affidea Polska in?

Affidea Polska's product category is Diagnostic Imaging and Oncology Services. Its primary akta.pro industry code is HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 621512 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales